Blood Transfusions in Preterm Infants

NCT ID: NCT05331235

Last Updated: 2022-04-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-05-01

Study Completion Date

2023-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A cross sectional study to assess the effect of blood transfusions on the outcome of preterm infants

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a cross sectional study carried on preterm infants who are staying in the hospital as "growers"; to gain weight. We will assess blood transfusion received by these preterm infants in details.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Red Blood Cells Preterm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Grower preterm infants

Exclusion Criteria

* Severe illness, Hypovolemic shock, Hypoxia, Oxygen therapy, Surgical intervention
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kasr El Aini Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Douaa El Saied El Sherbiny

Lecturer of Pediatrics, Cairo university

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dahlia El Sebaie, MD

Role: STUDY_DIRECTOR

Kasralainy hospital, Faculty of medicine, Cairo University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Douaa El Sherbiny, MD

Role: CONTACT

01000039725

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MS-49-2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Transfusion of Prematures Trial
NCT01702805 COMPLETED NA
Erythropoietin in HIE Neonate
NCT06590155 NOT_YET_RECRUITING EARLY_PHASE1
Safety and Efficacy of Oral Bovine Lactoferrin
NCT04094597 COMPLETED EARLY_PHASE1